| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/14/1993 | EP0550580A1 Uracil reductase inactivators |
| 07/14/1993 | EP0550446A1 Radioprotection by calcium antagonists |
| 07/14/1993 | EP0334889B1 Composition for treating obesity |
| 07/13/1993 | US5227369 Carbohydrate blocking agent which inhibits LHR-mediated binding of leukocytes to myelin |
| 07/08/1993 | WO1993012817A1 Therapeutic combinations useful in the treatment of gastroesophageal reflux disease |
| 07/08/1993 | WO1993012779A1 Compositions containing histamine-h2-receptor antagonists at low dosage |
| 07/08/1993 | WO1993012775A1 Pharmaceutical composition and process for the preparation thereof |
| 07/08/1993 | WO1993010743A3 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 07/08/1993 | CA2126231A1 Compositions containing histamine-h2-receptor antagonists at low dosage |
| 07/08/1993 | CA2125776A1 Pharmaceutical composition and process for the preparation thereof |
| 07/07/1993 | EP0549702A1 Uses of recombinant colony stimulating factor-1 |
| 07/07/1993 | EP0287633B1 Combinations of tumor necrosis factors and anti-inflammatory agents for treating malignant and non-malignant diseases |
| 07/06/1993 | US5225401 Endopeptidase inhibitors for congestive heart failure |
| 07/06/1993 | US5225238 Method for coating active principles with a ph-sensitive polymer |
| 07/06/1993 | CA1319886C Mixed micelle solutions |
| 06/30/1993 | EP0549441A1 Juvenile hormone agents for systemically treating ectoparasites |
| 06/30/1993 | EP0549267A1 Lip treatment composition |
| 06/30/1993 | EP0548448A1 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| 06/30/1993 | EP0548238A1 Non-aqueous liquid oral suspensions |
| 06/29/1993 | US5223540 Fluvoxamine |
| 06/29/1993 | US5223490 Treating breast cancer |
| 06/29/1993 | US5223258 Antiviral disinfecting composition and method of inactivating the aids virus in vitro |
| 06/29/1993 | CA1319609C Carcass quality |
| 06/27/1993 | CA2075346A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 06/24/1993 | WO1993012221A1 Association between a human immunodeficiency virus-related retrovirus and autoimmune disease |
| 06/24/1993 | WO1993011797A1 Drug containing an atriopeptidase inhibitor and at least one calcic antagonist |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/24/1993 | WO1993011773A1 New combination of formoterol and budesonide |
| 06/24/1993 | WO1993011771A1 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease |
| 06/24/1993 | WO1993011744A1 Medicaments |
| 06/24/1993 | WO1993011743A1 Medicaments |
| 06/24/1993 | WO1993011735A1 Treatment of fungal infections |
| 06/24/1993 | WO1993011668A1 Methods and compositions for reducing multi-drug resistance |
| 06/24/1993 | CA2654849A1 Fluorocarbon aerosol medicaments |
| 06/24/1993 | CA2356145A1 New combination of formoterol and budesonide |
| 06/24/1993 | CA2125404A1 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease |
| 06/24/1993 | CA2125279A1 Methods and compositions for reducing multi-drug resistance |
| 06/23/1993 | EP0547334A1 Combination of calcium antagonists with cholinesterase inhibitors for the treatment of senile demention |
| 06/23/1993 | EP0547172A1 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 06/23/1993 | EP0272278B1 $i(D)-GL CONJUGATE THERAPY |
| 06/22/1993 | US5221688 Gastrointestinal disorders |
| 06/22/1993 | CA1319323C Medicaments for the treatment of emesis |
| 06/22/1993 | CA1319321C Pharmaceutical preparations |
| 06/21/1993 | CA2085639A1 Lip treatment composition |
| 06/16/1993 | EP0546870A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 06/16/1993 | EP0546676A1 Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| 06/16/1993 | EP0546160A1 Method of reversing local anesthesia and reagent system therefor |
| 06/16/1993 | EP0545946A1 Growth-promoting agent |
| 06/16/1993 | CN1073095A Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| 06/15/1993 | US5219886 Cardiovascular disorders, analgesics, enzyme inhibitors |
| 06/15/1993 | US5219877 Fungicide. antiinflammatory agents |
| 06/15/1993 | CA1319099C Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction) |
| 06/14/1993 | CA2085212A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 06/10/1993 | WO1993010808A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 06/10/1993 | WO1993010743A2 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 06/10/1993 | CA2124591A1 Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 06/09/1993 | EP0545147A2 Use of radical scavengers and/or substances suitable for deactivating nonradical reactive oxygen species for preventing or delaying human hair greying |
| 06/09/1993 | EP0544878A1 Asialoglycoprotein-conjugated medicinal agent |
| 06/09/1993 | EP0368920B1 Lectines fixing beta-d-galactoside |
| 06/09/1993 | CN1072863A Enhandced skin penetration system for improved topical delivery of drugs |
| 06/08/1993 | CA1318851C2 Cough/cold mixtures comprising non-sedating antihistamine drugs |
| 06/02/1993 | CN1072602A Enhanced skin penetration system for improved topical delivery of drugs |
| 06/02/1993 | CN1072601A Use of combination of angiotensin-converting enzyme inhibitor and calcium antagonist for treatment of proteinuria |
| 06/01/1993 | US5216025 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 06/01/1993 | US5215991 Administering amiloride and an imidazolidine derivative |
| 06/01/1993 | US5215750 L-glutamine and vitamin-containing compositions effective for inducing weight loss and for weight control |
| 06/01/1993 | CA1318686C Catechol derivatives, a process of preparation thereof, and therapeutical compositions containing the same |
| 06/01/1993 | CA1318594C Beta blockers for the treatment of the progression of axial myopia in children |
| 05/27/1993 | WO1993010138A1 Anti-sense oligonucleotides for isotype-specific suppression of immunoglobulin production |
| 05/27/1993 | WO1993009805A1 Polar lipid composition of plant origin |
| 05/27/1993 | WO1993009782A1 Combination chemotherapy |
| 05/27/1993 | WO1993009769A1 Methods and compositions utilizing pure s(+) isomer fluoxetine |
| 05/27/1993 | WO1993009764A1 Combined virustatic antimediator (covam) treatment of common colds |
| 05/27/1993 | WO1993007866A3 Compositions and methods for therapy and prevention of cancer, aids, and anemia |
| 05/27/1993 | WO1993006812A3 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 05/27/1993 | WO1993000100A3 Wound cleanser |
| 05/27/1993 | CA2123585A1 Polar lipidic composition from plants |
| 05/27/1993 | CA2122719A1 Combined virustatic antimediator (covam) treatment of common colds |
| 05/27/1993 | CA2122132A1 Anti-sense oligonucleotides for isotype-specific suppression of immunoglobulin production |
| 05/26/1993 | EP0543001A1 Use of antiarrhythmic agents to lower cholesterol |
| 05/26/1993 | EP0542988A1 Improved euthanasia compositions |
| 05/26/1993 | EP0542977A1 Oral composition based on an antibiotic material and clay |
| 05/26/1993 | EP0542860A1 Immunosuppressive compositions |
| 05/26/1993 | CN1020893C Improved process for preparing vinyl ethers |
| 05/25/1993 | US5214030 Urogenital disorders |
| 05/25/1993 | CA1318251C Combined use of an antigestagen and a progesterone systhesis inhibitor of the trilostane and epostane type |
| 05/19/1993 | EP0541716A1 Novel methods and compositions for treatment of angiogenic diseases |
| 05/19/1993 | EP0541701A1 INTERLEUKIN-4 AND INTERLEUKIN-1$g(b) SYNERGISTICALLY INDUCE VCAM-1 |
| 05/18/1993 | US5212290 Monoclonal and polyclonal antibodies |
| 05/18/1993 | US5212165 Enzyme inhibitor |
| 05/13/1993 | WO1993008809A1 Compositions containing k-252 compounds for potentiation of neurotrophin activity |
| 05/13/1993 | WO1993008790A1 Treatment of acne or of pseudofolliculitis barbae |
| 05/13/1993 | CA2123096A1 Compositions containing k-252 compounds for potentiation of neurotrophin activity |
| 05/12/1993 | EP0541214A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 05/12/1993 | EP0540859A1 Anthracycline prodrugs |
| 05/12/1993 | EP0540767A1 Treatment of lyso paf-mediated diseases with paf antagonists and procedure for determining their efficacy |
| 05/12/1993 | EP0540766A1 Treatment of eosinophil-mediated diseases with Paf antagonists and procedure for determining their efficacy. |
| 05/12/1993 | EP0413694B1 Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker |
| 05/11/1993 | US5210076 Methods of treating Parkinson's disease using melanin |
| 05/11/1993 | US5209920 Arthritis, administering a stimulant for the hypothalamic-pituitary adrenal axis and measuring hormone level |